Account
Articles
05.03.2024
VPAG for manufacturers: boom or gloom for UK launc...

We discuss the 2024 VPAG agreement, how it differs from the previous VPAS and whether this will impa...

Read more
Webinar
28.02.2024
VPAS is dead, long live VPAG: the impact of the UK...

Webinar: Discussions on the new Voluntary Scheme for Branded Medicines, Pricing, Access and Growth (...

Read more
Articles
15.02.2024
PATT 2.0: NICE Priorities & Pharma Impact

We examine the effects on patient access, specifically regarding pathways, high value steps, multi-i...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.

Talk to an expert

Remap Consulting have significant experience working with pharmaceutical and biotech companies in helping them navigate global market access.​

Get in touch